George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.40
Bid: 133.80
Ask: 134.60
Change: 6.60 (5.16%)
Spread: 0.80 (0.598%)
Open: 129.60
High: 137.20
Low: 129.00
Prev. Close: 127.80
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding & Total Voting Rights

9 Aug 2017 12:40

RNS Number : 5501N
NCC Group PLC
09 August 2017
 

 

NCC Group plc

 

("NCC" or the "Company")

 

Exercise of Share Options

 

Director / PDMR Dealing

 

NCC Group plc (LSE: NCC) received notification on 4 August 2017 that on the same day the Person Discharging Managerial Responsibilities ("PDMR") listed below was awarded 18,372 ordinary shares of 1 pence each in the Company ("Ordinary Shares") by the trustees of NCC Group Employee Benefit Trust ("EBT") pursuant to options granted to him under the Deferred Bonus Plan (part of the Company's Long Term Incentive Plan). The aggregate exercise price paid by the PDMR in relation to the options exercised by him was £1. The Ordinary Shares required to satisfy the award were acquired in the market by the EBT at a price of £1.9475 per Ordinary Share.

 

On 4 August 2017, the trustees of the EBT sold 8,634 Ordinary Shares on behalf of the PDMR at a price of £1.9475 per Ordinary Share to satisfy the costs of the income tax, national insurance and other liabilities arising on the exercise of the options.

 

As a result of the exercise of the options and the subsequent sale of Ordinary Shares mentioned above, the net number of Ordinary Shares acquired by the PDMR is set out below:

 

Name

Director / PDMR

Former shareholding

Ordinary Shares awarded

Ordinary Shares sold

Resultant shareholding

Percentage of issued share capital

Roger Rawlinson**

PDMR

966,571

18,372

8,634

976,309

0.353%

 

** Including 41,454 shares held by spouse

 

Total voting rights

 

Following the transactions above, the total Ordinary Shares in issue is 276,510,137. The number of voting rights in issue is 276,510,137 and should be used by shareholders as the denominator in the calculation of their interest in the Company.

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation. 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Roger Rawlinson

2

 

Reason for the notification

 

a)

 

Position/status

 

PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

NCC Group plc

b)

 

LEI

 

213800DJCGZRB6523934

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares

 

 

 

ISIN: GB00B01QGK86

b)

 

Nature of the transaction

 

 

1. Exercise of options over Ordinary Shares

2. Subsequent sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

1. Purchase of Ordinary Shares pursuant to exercise of options

Price(s)

Volume(s)

£1.00 (paid in total for all 18,372 Ordinary Shares) 

18,372

2. Sale of Ordinary Shares

Price(s)

Volume(s)

£1.9475 

8,634

 

 

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

As above

 

 

 

e)

 

Date of the transaction

 

4 August 2017

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

 

Enquiries:

 

NCC Group (www.nccgroup.trust)

Brian Tenner, Interim CEO

 

Peel Hunt

0161 209 5200

Charlie Batten/Dan Webster/George Sellar

020 7418 8900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKOARBWAWRAR
Date   Source Headline
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review
20th Jul 20234:51 pmRNSHolding(s) in Company
19th Jul 20234:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.